Carl Zeiss Meditec AG

AFX: XETR (DEU)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
S<jLOCK|z&@YRLOCK|#L!Ds<

Zeiss Ends 2024 on Soft Footing From Marketwide Challenges, but Favorable Long-Term Drivers Intact

Business Strategy and Outlook

Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices, or OPT, and microsurgery, or MCS.

Sponsor Center